Inactive Instrument

Forest Laboratories, Inc. Stock

Stocks

End-of-day quote NYSE Other stock markets
- ^USD	-

14-05-06	Actavis : Factbox - M&A frenzy transforming global pharma	RE
14-05-06	Actavis : M&A frenzy in healthcare sector	RE

14-05-06	Actavis : Factbox - M&A frenzy transforming global pharma	RE
14-05-06	Actavis : M&A frenzy in healthcare sector	RE
14-04-14	Actavis : Investors support deals spree, happy to see U.S. companies buy growth	RE
14-04-10	Icahn backs down from demand that eBay spin off PayPal	RE
14-02-20	Suntory Beverage & Food Ltd : Goldman Sachs misses out on WhatsApp, 2014's top deals so far	RE
14-02-18	Icahn says Actavis-Forest deal validates shareholder activism	RE
14-02-18	Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
14-02-18	Actavis PLC : Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
14-02-18	Actavis PLC : Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ	RE
14-01-08	S&P 500 ends flat in wake of Fed minutes	RE
14-01-08	Forest Laboratories, Inc. : Forest Labs to buy Aptalis from TPG for $2.9 billion	RE
14-01-07	Evercore Partners Inc. : Forest Labs nears $3 billion deal for Aptalis - source	RE
13-10-23	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE

14-06-30	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest	BU
14-06-30	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results	BU
14-06-23	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)	BU
14-06-23	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development	BU
14-06-20	Forest Laboratories : to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress	BU

16-11-17	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
14-04-28	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue
14-04-28	Wall Street ouvre en hausse, les pharmaceutiques en vue
14-04-28	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars
14-04-28	Forest Laboratories : Pharmacie-Forest achète Furiex pour $1,46 milliard

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+2.16%	+7.62%	+43.83%	+160.28%	1,013B
JOHNSON & JOHNSON	-0.07%	+6.76%	+52.34%	+48.95%	574B
ABBVIE INC.	-0.08%	+3.52%	+18.61%	+62.66%	397B
ROCHE HOLDING AG	-0.37%	+4.97%	+21.24%	+15.95%	324B
ASTRAZENECA PLC	+0.85%	+2.79%	+24.89%	+15.93%	280B
NOVARTIS AG	+2.10%	+7.06%	+24.57%	+34.79%	273B
AMGEN INC.	+4.84%	+4.68%	+20.66%	+61.85%	182B
NOVO NORDISK A/S	-0.19%	+3.96%	-45.64%	-48.23%	194B
GILEAD SCIENCES, INC.	+3.61%	-2.42%	+14.33%	+61.12%	151B
Average	+1.66%	+2.65%	+19.42%	+45.92%	376.52B
Weighted average by Cap.	+1.35%	+3.99%	+29.36%	+72.50%